Clinical Trials | June 13, 2026
Ryvu advances romaciclib program as FDA clears AML trial expansion
The regulatory decision follows promising results from RIVER-81
The regulatory decision follows promising results from RIVER-81
Subscribe To Our Newsletter & Stay Updated